Gemigliptin 50mg
Sponsors
LG Life Sciences, LG Chem
Conditions
Diabetes Mellitus, Type 2Type 2 Diabetes Mellitus
Phase 1
Phase 3
Phase III Trial to Evaluate the Efficacy and Safety of Initial Combination Therapy With Gemigliptin 50mg q.d and Metformin q.d
CompletedNCT01787396
Start: 2013-04-30End: 2015-03-31Updated: 2015-04-03
A Study to Evaluate the Efficacy and Safety of Gemigliptin in Type 2 Diabetes Who Have Inadequate GlycemIc Control With Dapagliflozin and Metformin (SOLUTION Study)
CompletedNCT03842267
Start: 2019-05-13End: 2022-11-30Updated: 2023-03-10
A Study to Evaluate the Efficacy and Safety of Dual add-on Therapy With Gemigliptin 50 mg and Dapagliflozin 10 mg Added to Metformin Who Have Inadequate Glycemic Control on Metformin Alone
NCT04255238
Start: 2020-06-30End: 2022-12-30Target: 468Updated: 2020-02-19